Freezing lung biopsies: a safer way to diagnose?

NCT ID NCT07301697

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study is testing a newer technique called cryobiopsy, which uses a freezing probe to take tissue samples from the lungs. The goal is to see how safe and accurate it is for diagnosing conditions like lung disease, tumors, or infections. Researchers at a French hospital will study 30 patients who need this procedure, comparing results to standard methods. If it works well, it could offer a less invasive option for getting a clear diagnosis.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
cryobiopsy (a procedure using a freezing probe to take tissue samples)
What this could lead to
If successful, this study could help establish cryobiopsy as a standard, safer diagnostic tool for lung conditions, potentially replacing more invasive methods.
What could go wrong
This is a small, single-center study with only 30 participants, so results may not apply broadly. The procedure carries risks like bleeding or infection, and it may not outperform existing techniques.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIFFUSE INTERSTITIAL LUNG DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Pulmonology Department - NHC Strasbourg

    RECRUITING

    Strasbourg, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.